On this episode of "Halteres Presents", hosts Mickey Urdea and Rich Thayer are sitting down with Eric A. Klein, MD, to get his perspective on the value of a molecular cancer signal of origin in guiding targeted diagnostic evaluations based on his real-world experience overseeing GRAIL's clinical development program spanning 9 clinical trials and diverse populations, including those with occupational exposure, and more than 350,000 Galleri tests run. He also opines on what could make multi-cancer early detections tests more widely adopted and how to broaden the definition of clinical utility for reimbursement in MCED testing. Please enjoy this episode of "Halteres Presents".

Eric A. Klein, MD is a Distinguished Scientist at GRAIL. Previously he served as the Andrew C. Novick Distinguished Professor and Chair of the Glickman Urological and Kidney Institute and Lerner College of Medicine of the Cleveland Clinic, where he was also a member of the Department of Cancer Biology of the Cleveland Clinic Lerner Research Institute, the Taussig Cancer Institute, and the Genitourinary Malignancies Program in the Case Comprehensive Cancer Center. Dr. Klein was a Fellow in the Distinguished Careers Institute at Stanford University in 2022 and joined GRAIL in 2023. His recent work has focused on the clinical development of multicancer early detection tests.

This episode of "Halteres Presents" is brought to you by the UC San Diego Division of Extended Studies, where courses are designed for professionals looking to deepen their expertise in the biotech space. Their core course, In Vitro Diagnostics Product Development, offers a practical, end-to-end look at taking an IVD product from concept to regulatory approval. You’ll learn about product requirements, assay development, instrumentation, risk analysis, and key clinical and regulatory considerations. Learn more about the In Vitro Diagnostics Product Development course ⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠.

You can also broaden your skills with their Precision Medicine and Companion Diagnostics course, which covers biomarker-driven development, CDx/therapeutic co-development, and the expanding role of precision medicine. Learn more about the Precision Medicine and Companion Diagnostics course ⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠.

Use our exclusive discount code HALTERES10 at checkout for 10% off the price of your enrollment.

Advance your diagnostics career with UC San Diego Extended Studies - your next step in biotech starts here.

Learn more about Halteres Associates ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

On this episode of "Halteres Presents", hosts Mickey Urdea and Rich Thayer are sitting down with Dr. Beth Marlowe, Executive Scientific Director and Head of R&D for Quest Diagnostics Infectious Diseases, for an in-depth discussion on how “Home to Lab” remote specimen collection and other at-home testing options have shifted the patient journey, what is needed to support the changing paradigm, and how to reduce barriers for diagnostic testing. Please enjoy this episode of "Halteres Presents".

Dr. Elizabeth (Beth) Marlowe is the Executive Scientific Director and heads R&D for Quest Diagnostics Infectious Diseases and Immunology. Dr Marlowe joined Quest in June of 2019. Beginning January of 2020, her team played a key role in the COVID-19 response and in 2022 the Mpox response.

Previously she worked as the global director of medical affairs for microbiology at Roche Molecular Systems, provided laboratory leadership for over a decade within the Kaiser Permanente Regional Laboratories and worked on assay development for Gen-Probe (now Hologic).

She is a diplomat of the American Board of Medical Microbiology, past-president for the So Cal branch of the American Society for Microbiology (ASM), served as an editor for the Clinical Microbiology Newsletter as well as the Journal of Clinical Virology. She has served as an elected member to the Council on Microbial Sciences for ASM, an appointed member of CLIAC, the federal advisory committee for CLIA to the United Stated Health and Human Services Secretary and an elected member of the Board of Directors for ASM. Her research areas of interest are focused on the translation of new infectious disease diagnostics for use in evidence-based research for clinical and public health microbiology practice.

This episode of "Halteres Presents" is brought to you by the UC San Diego Division of Extended Studies, where courses are designed for professionals looking to deepen their expertise in the biotech space. Their core course, In Vitro Diagnostics Product Development, offers a practical, end-to-end look at taking an IVD product from concept to regulatory approval. You’ll learn about product requirements, assay development, instrumentation, risk analysis, and key clinical and regulatory considerations. Learn more about the In Vitro Diagnostics Product Development course ⁠⁠⁠⁠HERE⁠⁠⁠⁠.

You can also broaden your skills with their Precision Medicine and Companion Diagnostics course, which covers biomarker-driven development, CDx/therapeutic co-development, and the expanding role of precision medicine. Learn more about the Precision Medicine and Companion Diagnostics course ⁠⁠⁠⁠HERE⁠⁠⁠⁠.

Use our exclusive discount code HALTERES10 at checkout for 10% off the price of your enrollment.

Advance your diagnostics career with UC San Diego Extended Studies - your next step in biotech starts here.

Learn more about Halteres Associates ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.